Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) IDENTIFICATION OF SELECTIVE INHIBITORS OF COLLAGENASE-1 (METALLOPROTEINASE 1 (MMP-1))

被引:34
作者
Bahudhanapati, Harinath [1 ]
Zhang, Yingnan [2 ]
Sidhu, Sachdev S. [2 ]
Brew, Keith [1 ]
机构
[1] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Basic Sci, Boca Raton, FL 33431 USA
[2] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
基金
美国国家卫生研究院;
关键词
KUNITZ DOMAIN INHIBITORS; ALPHA-CONVERTING-ENZYME; FACTOR-FACTOR VIIA; MATRIX-METALLOPROTEINASES; CRYSTAL-STRUCTURE; ITERATIVE OPTIMIZATION; CATALYTIC DOMAIN; POTENT INHIBITOR; BREAST-CANCER; SWISS-MODEL;
D O I
10.1074/jbc.M111.253328
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue inhibitor of metalloproteinases-2 (TIMP-2) is a broad spectrum inhibitor of the matrix metalloproteinases (MMPs), which function in extracellular matrix catabolism. Here, phage display was used to identify variants of human TIMP-2 that are selective inhibitors of human MMP-1, a collagenase whose unregulated action is linked to cancer, arthritis, and fibrosis. Using hard randomization of residues 2, 4, 5, and 6 (L1) and soft randomization of residues 34-40 (L2) and 67-70 (L3), a library was generated containing 2 x 10(10) variants of TIMP-2. Five clones were isolated after five rounds of selection with MMP-1, using MMP-3 as a competitor. The enriched phages selectively bound MMP-1 relative to MMP-3 and contained mutations only in L1. The most selective variant (TM8) was used to generate a second library in which residues Cys(1)-Gln(9) were soft-randomized. Four additional clones, selected from this library, showed a similar affinity for MMP-1 as wild-type TIMP-2 but reduced affinity for MMP-3. Variants of the N-terminal domain of TIMP-2 (N-TIMP-2) with the sequences of the most selective clones were expressed and characterized for inhibitory activity against eight MMPs. All were effective inhibitors of MMP-1 with nanomolar K-i values, but TM8, containing Ser(2) to Asp and Ser(4) to Ala substitutions, was the most selective having a nanomolar K-i value for MMP-1 but no detectable inhibitory activity toward MMP-3 and MMP-14 up to 10 mu M. This study suggests that phage display and selection with other MMPs may be an effective method for discovering tissue inhibitor of metalloproteinase variants that discriminate between specified MMPs as targets.
引用
收藏
页码:31761 / 31770
页数:10
相关论文
共 41 条
[21]   A protective role for matrix metalloproteinase-3 in squamous cell carcinoma [J].
McCawley, LJ ;
Crawford, HC ;
King, LE ;
Mudgett, J ;
Matrisian, LM .
CANCER RESEARCH, 2004, 64 (19) :6965-6972
[22]   Genes that mediate breast cancer metastasis to lung [J].
Minn, AJ ;
Gupta, GP ;
Siegel, PM ;
Bos, PD ;
Shu, WP ;
Giri, DD ;
Viale, A ;
Olshen, AB ;
Gerald, WL ;
Massagué, J .
NATURE, 2005, 436 (7050) :518-524
[23]   Progress in matrix metalloproteinase research [J].
Murphy, Gillian ;
Nagase, Hideaki .
MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (05) :290-308
[24]   Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer [J].
Murray, GI ;
Duncan, ME ;
ONeil, P ;
Melvin, WT ;
Fothergill, JE .
NATURE MEDICINE, 1996, 2 (04) :461-462
[25]   Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9 - Differential rates for activation by stromelysin 1 [J].
Olson, MW ;
Bernardo, MM ;
Pietila, M ;
Gervasi, DC ;
Toth, M ;
Kotra, LP ;
Massova, I ;
Mobashery, S ;
Fridman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2661-2668
[26]   Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy [J].
Overall, CM ;
Kleifeld, O .
NATURE REVIEWS CANCER, 2006, 6 (03) :227-239
[27]   UCSF chimera - A visualization system for exploratory research and analysis [J].
Pettersen, EF ;
Goddard, TD ;
Huang, CC ;
Couch, GS ;
Greenblatt, DM ;
Meng, EC ;
Ferrin, TE .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) :1605-1612
[28]   Origins of PDZ domain ligand specificity - Structure determination and mutagenesis of the erbin PDZ domain [J].
Skelton, NJ ;
Koehler, MFT ;
Zobel, K ;
Wong, WL ;
Yeh, S ;
Pisabarro, MT ;
Yin, JP ;
Lasky, LA ;
Sidhu, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7645-7654
[29]   Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19 -: Evidence for a role as a potent basement membrane degrading enzyme [J].
Stracke, JO ;
Hutton, M ;
Stewart, M ;
Pendás, AM ;
Smith, B ;
López-Otin, C ;
Murphy, G ;
Knäuper, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :14809-14816
[30]   Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries [J].
Tonikian, Raffi ;
Zhang, Yingnan ;
Boone, Charles ;
Sidhu, Sachdev S. .
NATURE PROTOCOLS, 2007, 2 (06) :1368-1386